Clinical Potential of Long Non-Coding Rna Linc01133 As A Promising Biomarker and Therapeutic Target in Cancers

References

• Hanahan D , WeinbergRA. Hallmarks of cancer: the next generation. Cell144(5), 646–674 (2011).
   PubMed Web of Science ®Google Scholar
• Sung H , FerlayJ, SiegelRLet al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. doi:10.3322/caac.21660 (2021) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Ling H , VincentK, PichlerMet al. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene34(39), 5003–5011 (2015).
   PubMed Web of Science ®Google Scholar
• Batista PJ , ChangHY. Long noncoding RNAs: cellular address codes in development and disease. Cell152(6), 1298–1307 (2013).
   PubMed Web of Science ®Google Scholar
• Ulitsky I , ShkumatavaA, JanCH, SiveH, BartelDP. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell147(7), 1537–1550 (2011).
   PubMed Web of Science ®Google Scholar
• Fatica A , BozzoniI. Long non-coding RNAs: new players in cell differentiation and development. Nat. Rev. Genet.15(1), 7–21 (2014).
   PubMed Web of Science ®Google Scholar
• Wapinski O , ChangHY. Long noncoding RNAs and human disease. Trends Cell Biol.21(6), 354–361 (2011).
   PubMed Web of Science ®Google Scholar
• Tamang S , AcharyaV, RoyDet al. SNHG12: an LncRNA as a potential therapeutic target and biomarker for human cancer. Front. Oncol.9, 901 (2019).
   PubMed Web of Science ®Google Scholar
• Zang C , NieFQ, WangQet al. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer. Oncotarget7(10), 11696–11707 (2016).
   PubMedGoogle Scholar
• Xie CR , WangF, ZhangSet al. Long noncoding RNA HCAL facilitates the growth and metastasis of hepatocellular carcinoma by acting as a ceRNA of LAPTM4B. Mol. Ther. Nucleic Acids9, 440–451 (2017).
   PubMedGoogle Scholar
• Shen J , HongL, YuD, CaoT, ZhouZ, HeS. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression. Int. J. Biochem. Cell Biol.113, 17–26 (2019).
   PubMed Web of Science ®Google Scholar
• Liu H , DengH, ZhaoY, LiC, LiangY. LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. J. Exp. Clin. Cancer Res.37(1), 279 (2018).
   PubMedGoogle Scholar
• Xing F , LiuY, WuSYet al. Loss of XIST in breast cancer activates MSN-c-Met and reprograms microglia via exosomal miRNA to promote brain metastasis. Cancer Res.78(15), 4316–4330 (2018).
   PubMed Web of Science ®Google Scholar
• Kangarlouei R , IraniS, NoormohammadiZ, MemariF, MirfakhraieR. ANRIL and ANRASSF1 long noncoding RNAs are upregulated in gastric cancer. J. Cell. Biochem.120(8), 12544–12548 (2019).
   PubMed Web of Science ®Google Scholar
• Yao F , WangQ, WuQ. The prognostic value and mechanisms of lncRNA UCA1 in human cancer. Cancer Manag. Res.11, 7685–7696 (2019).
   PubMed Web of Science ®Google Scholar
• Chang L , GuoR, YuanZ, ShiH, ZhangD. LncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging miR-206 in ovarian cancer. Cell Physiol. Biochem.49(4), 1289–1303 (2018).
   PubMedGoogle Scholar
• Xue X , YangYA, ZhangAet al. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogene35(21), 2746–2755 (2016).
   PubMed Web of Science ®Google Scholar
• Chen Z , HeA, WangD, LiuY, HuangW. Long noncoding RNA HOTTIP as a novel predictor of lymph node metastasis and survival in human cancer: a systematic review and meta-analysis. Oncotarget8(8), 14126–14132 (2017).
   PubMedGoogle Scholar
• Shi SH , JiangJ, ZhangWet al. A novel lncRNA HOXC-AS3 acts as a miR-3922-5p sponge to promote breast cancer metastasis. Cancer Invest.38(1), 1–12 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang E , HeX, ZhangCet al. A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome Biol.19(1), 154 (2018).
   PubMed Web of Science ®Google Scholar
• Sun Y , MaL. New insights into long non-coding RNA MALAT1 in cancer and metastasis. Cancers (Basel)11(2), 216 (2019).
   PubMed Web of Science ®Google Scholar
• Li C , ZhaoZ, ZhouZ, LiuR. Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis. Cancer Chemother. Pharmacol.78(6), 1199–1207 (2016).
   PubMed Web of Science ®Google Scholar
• Wang J , ZouJX, XueXet al. ROR-gamma drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Nat. Med.22(5), 488–496 (2016).
   PubMed Web of Science ®Google Scholar
• Sharma U , BarwalTS, AcharyaV, TamangS, VasquezKM, JainA. Cancer susceptibility candidate 9 (CASC9): a novel targetable long noncoding RNA in cancer treatment. Transl. Oncol.13(8), 100774 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang K , LiuP, TangHet al. AFAP1-AS1 promotes epithelial–mesenchymal transition and tumorigenesis through Wnt/beta-catenin signaling pathway in triple-negative breast cancer. Front. Pharmacol.9, 1248 (2018).
   PubMed Web of Science ®Google Scholar
• Tang XD , ZhangDD, JiaL, JiW, ZhaoYS. lncRNA AFAP1-AS1 promotes migration and invasion of non-small cell lung cancer via up-regulating IRF7 and the RIG-I-like receptor signaling pathway. Cell Physiol. Biochem.50(1), 179–195 (2018).
   PubMedGoogle Scholar
• Huang CS , ChuJ, ZhuXXet al. The C/EBPbeta-LINC01133 axis promotes cell proliferation in pancreatic ductal adenocarcinoma through upregulation of CCNG1. Cancer Lett.421, 63–72 (2018).
   PubMed Web of Science ®Google Scholar
• Sharma U , BarwalTS, MalhotraAet al. Long non-coding RNA TINCR as potential biomarker and therapeutic target for cancer. Life Sci.257, 118035 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang W , DuM, WangTet al. Long non-coding RNA LINC01133 mediates nasopharyngeal carcinoma tumorigenesis by binding to YBX1. Am. J. Cancer Res.9(4), 779–790 (2019).
   PubMed Web of Science ®Google Scholar
• Yang XZ , ChengTT, HeQJet al. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/beta-catenin pathway. Mol. Cancer17(1), 126 (2018).
   PubMed Web of Science ®Google Scholar
• Song Z , ZhangX, LinY, WeiY, LiangS, DongC. LINC01133 inhibits breast cancer invasion and metastasis by negatively regulating SOX4 expression through EZH2. J. Cell. Mol. Med.23(11), 7554–7565 (2019).
   PubMed Web of Science ®Google Scholar
• Weng YC , MaJ, ZhangJ, WangJC. Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway. Cancer Biol. Ther.20(3), 368–380 (2019).
   PubMed Web of Science ®Google Scholar
• Sharma U , BarwalTS, KhandelwalAet al. LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3. Biochimie182, 99–107 (2021).
   PubMed Web of Science ®Google Scholar
• Mishra K , KanduriC. Understanding long noncoding RNA and chromatin interactions: what we know so far. Noncoding RNA5(4), 54 (2019).
   PubMed Web of Science ®Google Scholar
• Fagerberg L , HallstromBM, OksvoldPet al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell Proteomics13(2), 397–406 (2014).
   PubMed Web of Science ®Google Scholar
• Kong J , SunW, ZhuW, LiuC, ZhangH, WangH. Long noncoding RNA LINC01133 inhibits oral squamous cell carcinoma metastasis through a feedback regulation loop with GDF15. J. Surg. Onco.118(8), 1326–1334 (2018).
   PubMed Web of Science ®Google Scholar
• Tu Z , SchmollerlJ, CuiffoBG, KarnoubAE. Microenvironmental regulation of long noncoding RNA LINC01133 promotes cancer stem cell-like phenotypic traits in triple-negative breast cancers. Stem Cells37(10), 1281–1292 (2019).
   PubMedGoogle Scholar
• Wang M , MaX, ZhuCet al. The prognostic value of long non coding RNAs in non small cell lung cancer: a meta-analysis. Oncotarget7(49), 81292–81304 (2016).
   PubMedGoogle Scholar
• Zhang J , ZhuN, ChenX. A novel long noncoding RNA LINC01133 is upregulated in lung squamous cell cancer and predicts survival. Tumour Biol.36(10), 7465–7471 (2015).
   PubMedGoogle Scholar
• Yang XZ , HeQJ, ChengTTet al. Predictive value of LINC01133 for unfavorable prognosis was impacted by alcohol in esophageal squamous cell carcinoma. Cell. Physiol. Biochem.48(1), 251–262 (2018).
   PubMedGoogle Scholar
• Foroughi K , AminiM, AtashiA, MahmoodzadehH, HamannU, ManoochehriM. Tissue-specific down-regulation of the long non-coding RNAs PCAT18 and LINC01133 in gastric cancer development. Int. J. Mol. Sci.19(12), 3881 (2018).
   PubMed Web of Science ®Google Scholar
• Zheng YF , ZhangXY, BuYZ. LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway. J. Cell. Biochem.120(3), 4172–4179 (2019).
   PubMed Web of Science ®Google Scholar
• Giulietti M , RighettiA, PrincipatoG, PivaF. LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer. Carcinogenesis39(8), 1016–1025 (2018).
   PubMed Web of Science ®Google Scholar
• Zhang JH , LiAY, WeiN. Downregulation of long non-coding RNA LINC01133 is predictive of poor prognosis in colorectal cancer patients. Eur. Rev. Med. Pharmacol. Sci.21(9), 2103–2107 (2017).
   PubMed Web of Science ®Google Scholar
• Kong J , SunW, LiCet al. Long non-coding RNA LINC01133 inhibits epithelial–mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6. Cancer Lett.380(2), 476–484 (2016).
   PubMed Web of Science ®Google Scholar
• Feng Y , QuL, WangX, LiuC. LINC01133 promotes the progression of cervical cancer by sponging miR-4784 to up-regulate AHDC1. Cancer Biol. Ther.20(12), 1453–1461 (2019).
   PubMed Web of Science ®Google Scholar
• Mao X , QinX, LiLet al. A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma. Gynecol. Oncol.149(1), 181–187 (2018).
   PubMed Web of Science ®Google Scholar
• Zeng HF , QiuHY, FengFB. Long Noncoding RNA LINC01133 functions as an miR-422a sponge to aggravate the tumorigenesis of human osteosarcoma. Oncol. Res.26(3), 335–343 (2018).
   PubMed Web of Science ®Google Scholar
• Liu S , XiX. LINC01133 contribute to epithelial ovarian cancer metastasis by regulating miR-495-3p/TPD52 axis. Biochem. Biophys. Res. Commun.533(4), 1088–1094 (2020).
   PubMed Web of Science ®Google Scholar
• Liu M , ShenC, WangC. Long noncoding RNA LINC01133 confers tumor-suppressive functions in ovarian cancer by regulating leucine-rich repeat kinase 2 as an miR-205 sponge. Am. J. Pathol.189(11), 2323–2339 (2019).
   PubMed Web of Science ®Google Scholar
• Li Z , XuD, ChenX, LiS, ChanMTV, WuWKK. LINC01133: an emerging tumor-associated long non-coding RNA in tumor and osteosarcoma. Environ. Sci. Pollut. Res. Int.27(26), 32467–32473 (2020).
   PubMed Web of Science ®Google Scholar
• Liberati A , AltmanDG, TetzlaffJet al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ339, b2700 (2009).
   PubMed Web of Science ®Google Scholar
• Siegel R , NaishadhamD, JemalA. Cancer statistics, 2013. CA Cancer J. Clin.63(1), 11–30 (2013).
   PubMed Web of Science ®Google Scholar
• Siegel R , NaishadhamD, JemalA. Cancer statistics, 2012. CA Cancer J. Clin.62(1), 10–29 (2012).
   PubMed Web of Science ®Google Scholar
• Pisani P , ParkinDM, BrayF, FerlayJ. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer83(1), 18–29 (1999).
   PubMed Web of Science ®Google Scholar
• Ramalingam S , PawlishK, GadgeelS, DemersR, KalemkerianGP. Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results database. J. Clin. Oncol.16(2), 651–657 (1998).
   PubMed Web of Science ®Google Scholar
• Jemal A , SiegelR, XuJ, WardE. Cancer statistics, 2010. CA Cancer J. Clin.60(5), 277–300 (2010).
   PubMed Web of Science ®Google Scholar
• Verdecchia A , FrancisciS, BrennerHet al. Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol.8(9), 784–796 (2007).
   PubMed Web of Science ®Google Scholar
• Wistuba II . Genetics of preneoplasia: lessons from lung cancer. Curr. Mol. Med.7(1), 3–14 (2007).
   PubMed Web of Science ®Google Scholar
• Klebe S , HendersonDW. Facts and fiction: premalignant lesions of lung tissues. Pathology45(3), 305–315 (2013).
   PubMed Web of Science ®Google Scholar
• Shen Q , YangXR, TanYet al. High level of serum protein DKK1 predicts poor prognosis for patients with hepatocellular carcinoma after hepatectomy. Hepat. Oncol.2(3), 231–244 (2015).
   PubMedGoogle Scholar
• Sahasrabuddhe VV , GunjaMZ, GraubardBIet al. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J. Natl Cancer Inst.104(23), 1808–1814 (2012).
   PubMedGoogle Scholar
• Spangenberg HC , ThimmeR, BlumHE. Advances in prevention and diagnosis of hepatocellular carcinoma. Expert Rev. Gastroenterol. Hepatol.2(3), 425–433 (2008).
   PubMedGoogle Scholar
• Wang M , WuH, LiSet al. SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling. Oncotarget8(52), 89692–89706 (2017).
   PubMedGoogle Scholar
• Wang H , WuQ, LiuZet al. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis.5, e1155 (2014).
   PubMed Web of Science ®Google Scholar
• Siegel RL , MillerKD, JemalA. Cancer Statistics, 2017. CA Cancer J. Clin.67(1), 7–30 (2017).
   PubMed Web of Science ®Google Scholar
• Hidalgo M . Pancreatic cancer. N. Engl. J. Med.362(17), 1605–1617 (2010).
   PubMed Web of Science ®Google Scholar
• Garrido-Laguna I , HidalgoM. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies. Nat. Rev. Clin. Oncol.12(6), 319–334 (2015).
   PubMed Web of Science ®Google Scholar
• Regalo G , ForsterS, ResendeCet al. C/EBPbeta regulates homeostatic and oncogenic gastric cell proliferation. J. Mol. Med. (Berl.)94(12), 1385–1395 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang J , GaoS, ZhangYet al. MiR-216a-5p inhibits tumorigenesis in pancreatic cancer by targeting TPT1/mTORC1 and is mediated by LINC01133. Int. J. Biol. Sci.16(14), 2612–2627 (2020).
   PubMed Web of Science ®Google Scholar
• Anastas JN , MoonRT. WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer13(1), 11–26 (2013).
   PubMed Web of Science ®Google Scholar
• Hirata H , HinodaY, NakajimaKet al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Int. J. Cancer128(8), 1793–1803 (2011).
   PubMed Web of Science ®Google Scholar
• Lamora A , TalbotJ, MullardM, Brounais-LeRoyer B, RediniF, VerrecchiaF. TGF-beta signaling in bone remodeling and osteosarcoma progression. J. Clin. Med.5(11), 96 (2016).
   PubMed Web of Science ®Google Scholar
• Verrecchia F , RediniF. Transforming growth factor-beta signaling plays a pivotal role in the interplay between osteosarcoma cells and their microenvironment. Front. Oncol.8, 133 (2018).
   PubMed Web of Science ®Google Scholar
• Liu S , ChenS, ZengJ. TGFbeta signaling: a complex role in tumorigenesis (Review). Mol. Med. Rep.17(1), 699–704 (2018).
   PubMed Web of Science ®Google Scholar
• Liu X , SunY, ConstantinescuSN, KaramE, WeinbergRA, LodishHF. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl Acad. Sci. USA94(20), 10669–10674 (1997).
   PubMed Web of Science ®Google Scholar
• Gierach GL , BurkeA, AndersonWF. Epidemiology of triple negative breast cancers. Breast Dis.32(1–2), 5–24 (2010).
   PubMedGoogle Scholar
• Cuiffo BG , CampagneA, BellGWet al. MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. Cell Stem Cell15(6), 762–774 (2014).
   PubMed Web of Science ®Google Scholar
• Ghaleb AM , YangVW. Kruppel-like factor 4 (KLF4): what we currently know. Gene611, 27–37 (2017).
   PubMed Web of Science ®Google Scholar
• Nagata T , ShimadaY, SekineSet al. KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer. Breast Cancer24(2), 326–335 (2017).
   PubMed Web of Science ®Google Scholar
• Ferlay J , ColombetM, SoerjomataramIet al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer144(8), 1941–1953 (2019).
   PubMed Web of Science ®Google Scholar
• Yu MC , YuanJM. Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol.12(6), 421–429 (2002).
   PubMed Web of Science ®Google Scholar
• Blanchard P , LeeA, MarguetSet al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol.16(6), 645–655 (2015).
   PubMed Web of Science ®Google Scholar
• Han L , LinSJ, PanJJet al. Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Chin. J. Cancer29(2), 145–150 (2010).
   PubMedGoogle Scholar
• Shi J , WangDM, WangCMet al. Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithelial–mesenchymal transition. Cancer Res.69(18), 7180–7187 (2009).
   PubMed Web of Science ®Google Scholar
• Yang J , ManiSA, DonaherJLet al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell117(7), 927–939 (2004).
   PubMed Web of Science ®Google Scholar
• Peinado H , PortilloF, CanoA. Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol.48(5–6), 365–375 (2004).
   PubMed Web of Science ®Google Scholar
• Zhou LL , NiJ, FengWTet al. High YBX1 expression indicates poor prognosis and promotes cell migration and invasion in nasopharyngeal carcinoma. Exp. Brain Res.361(1), 126–134 (2017).
   Google Scholar
• Pires FR , RamosAB, OliveiraJB, TavaresAS, LuzPS, SantosTC. Oral squamous cell carcinoma: clinicopathological features from 346 cases from a single oral pathology service during an 8-year period. J. Appl. Oral Sci.21(5), 460–467 (2013).
   PubMed Web of Science ®Google Scholar
• Fang J , LiX, MaDet al. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. BMC Cancer17(1), 375 (2017).
   PubMed Web of Science ®Google Scholar
• Omar EA . The outline of prognosis and new advances in diagnosis of oral squamous cell carcinoma (OSCC): review of the literature. J. Oral Oncol.2013 (2013).
   Google Scholar
• Jablonska-Trypuc A , MatejczykM, RosochackiS. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J. Enzyme Inhib. Med. Chem.31(Suppl. 1), 177–183 (2016).
   PubMedGoogle Scholar
• Jin YJ , LeeJH, KimYM, OhGT, LeeH. Macrophage inhibitory cytokine-1 stimulates proliferation of human umbilical vein endothelial cells by up-regulating cyclins D1 and E through the PI3K/Akt-, ERK-, and JNK-dependent AP-1 and E2F activation signaling pathways. Cell. Signal.24(8), 1485–1495 (2012).
   PubMed Web of Science ®Google Scholar
• Moreno CS . SOX4: the unappreciated oncogene. Semin. Cancer Biol.67(Pt 1), 57–64 (2020).
   PubMedGoogle Scholar
• Laugesen A , HojfeldtJW, HelinK. Role of the polycomb repressive complex 2 (PRC2) in transcriptional regulation and cancer. Cold Spring Harb. Perspect. Med.6(9), a026575 (2016).
   PubMed Web of Science ®Google Scholar
• Domper Arnal MJ , FerrandezArenas A, LanasArbeloa A. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J. Gastroenterol.21(26), 7933–7943 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang Y . Epidemiology of esophageal cancer. World J. Gastroenterol.19(34), 5598–5606 (2013).
   PubMed Web of Science ®Google Scholar
• Kollarova H , MachovaL, HorakovaD, JanoutovaG, JanoutV. Epidemiology of esophageal cancer – an overview article. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc. Czech. Repub.151(1), 17–20 (2007).
   PubMedGoogle Scholar
• Shimizu T , MarusawaH, MatsumotoYet al. Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection. Gastroenterology147(2), 407–417 e403 (2014).
   PubMed Web of Science ®Google Scholar
• Nagini S . Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J. Gastrointest. Oncol.4(7), 156–169 (2012).
   PubMed Web of Science ®Google Scholar
• Gigek CO , ChenES, CalcagnoDQ, WisnieskiF, BurbanoRR, SmithMA. Epigenetic mechanisms in gastric cancer. Epigenomics4(3), 279–294 (2012).
   PubMed Web of Science ®Google Scholar
• Bracken CP , ScottHS, GoodallGJ. A network-biology perspective of microRNA function and dysfunction in cancer. Nat. Rev. Genet.17(12), 719–732 (2016).
   PubMed Web of Science ®Google Scholar
• Clevers H , NusseR. Wnt/beta-catenin signaling and disease. Cell149(6), 1192–1205 (2012).
   PubMed Web of Science ®Google Scholar
• Rawla P , SunkaraT, BarsoukA. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz. Gastroenterol.14(2), 89–103 (2019).
   PubMed Web of Science ®Google Scholar
• Motohara T , KatabuchiH. Ovarian cancer stemness: biological and clinical implications for metastasis and chemotherapy resistance. Cancers11(7), 907 (2019).
   PubMed Web of Science ®Google Scholar
• Fortner RT , PooleEM, WentzensenNAet al. Ovarian cancer risk factors by tumor aggressiveness: an analysis from the Ovarian Cancer Cohort Consortium. Int. J. Cancer145(1), 58–69 (2019).
   PubMed Web of Science ®Google Scholar
• Oza AM , CookAD, PfistererJet al. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncol.16(8), 928–936 (2015).
   PubMed Web of Science ®Google Scholar
• Yang H , QuH, HuangHet al. Exosomes-mediated transfer of long noncoding RNA LINC01133 represses bladder cancer progression via regulating the Wnt signaling pathway. Cell Biol. Int. doi:10.1002/cbin.11590 (2021) ( Epub ahead of print).
   Web of Science ®Google Scholar
• Yang W , YueY, YinF, QiZ, GuoR, XuY. LINC01133 and LINC01243 are positively correlated with endometrial carcinoma pathogenesis. Arch. Gynecol. Obstet.303(1), 207–215 (2021).
   PubMed Web of Science ®Google Scholar
• Van Audenhove I , GettemansJ. Nanobodies as versatile tools to understand, diagnose, visualize and treat cancer. EBioMedicine8, 40–48 (2016).
   PubMed Web of Science ®Google Scholar
• Watrin M , Von PelchrzimF, DausseE, SchroederR, ToulmeJJ. In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1. Biochemistry48(26), 6278–6284 (2009).
   PubMed Web of Science ®Google Scholar
• Kong J , SunW, LiCet al. Long non-coding RNA LINC01133 inhibits epithelial–mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6. Cancer Lett.380(2), 476–484 (2016).
   PubMed Web of Science ®Google Scholar